Sort   by:  
 Page size 
UnknownCognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder.
Not available
S-EPMC12392052 | biostudies-literature
UnknownSystematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson's Disease.
Not available
S-EPMC11965473 | biostudies-literature
UnknownImproving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study.
Not available
S-EPMC12423612 | biostudies-literature
UnknownAssessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Not available
S-EPMC10627170 | biostudies-literature
UnknownClinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
Not available
S-EPMC5098340 | biostudies-literature
UnknownCSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
Not available
S-EPMC5031365 | biostudies-literature
UnknownDiagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
Not available
S-EPMC4575273 | biostudies-literature
UnknownLRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts.
Not available
S-EPMC9974978 | biostudies-literature
UnknownNeuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts.
Not available
S-EPMC11419206 | biostudies-literature
UnknownAssociation of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT.
Not available
S-EPMC6938559 | biostudies-literature
Sort   by:  
 Page size